Journal of Postgraduate Medicine, Education and Research

Register      Login

VOLUME 49 , ISSUE 3 ( July-September, 2015 ) > List of Articles

RESEARCH ARTICLE

Perinatal Transmission of HIV in Women Receiving Antiretroviral Prophylaxis/Therapy during Pregnancy with Zidovudine, Lamivudine, and Nevirapine: Experience at Tertiary Care Center in India

Sunil Arora, Khushbu Meena, Aashima Arora

Citation Information : Arora S, Meena K, Arora A. Perinatal Transmission of HIV in Women Receiving Antiretroviral Prophylaxis/Therapy during Pregnancy with Zidovudine, Lamivudine, and Nevirapine: Experience at Tertiary Care Center in India. J Postgrad Med Edu Res 2015; 49 (3):115-120.

DOI: 10.5005/jp-journals-10028-1159

Published Online: 01-06-2017

Copyright Statement:  Copyright © 2015; The Author(s).


Abstract

Objective

To compare the perinatal transmission rate, maternal and neonatal outcome among HIV positive women on triple drug antiretroviral therapy (ART) with women receiving antiretroviral (ARV) prophylaxis for prevention of mother to child transmission (MTCT).

Materials and methods

This prospective study recruited all HIV positive antenatal women who delivered at Postgraduate Institute of Medical Education and Research, Chandigarh from June 2010 to December 2011. The rate of HIV perinatal transmission was calculated in the two groups. The perinatal outcome was studied in the form of birth weight, gestation at delivery, mode of delivery, maternal morbidity and mortality.

Results

The overall HIV transmission rate was 13.3% (10% in ART group and 15% in ARV group). A trend was seen toward a lower MTCT among women in ARV prophylaxis group who delivered by elective cesarean section (CS) as compared to vaginal delivery (7.7 vs 16.7%).

Conclusion

The vertical transmission rate of HIV was lower among women receiving triple drug ART. The mode of delivery did not affect the transmission rate in this group.

How to cite this article

Meena K, Arora A, Bagga R, Kalra J, Kumar P, Sharma A, Arora S. Perinatal Transmission of HIV in Women Receiving Antiretroviral Prophylaxis/Therapy during Pregnancy with Zidovudine, Lamivudine, and Nevirapine: Experience at Tertiary Care Center in India. J Postgrad Med Edu Res 2015;49(3):115-120.


PDF Share
  1. NACO 2005.
  2. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment: Pediatric AIDS Clinical Trials Group Protocol 076 study group. Engl J Med 1994;331:1173-1180.
  3. Antiretroviral therapy of HIV infection in infants and children in resource-limited settings: towards universal access. Recommendations for a public health approach. Geneva: World Health Organization;. Recommendations for a public health approach. Geneva: World Health Organization; 2006.
  4. NACO, December, 2013.
  5. ACOG committee opinion scheduled Cesarean delivery and the prevention of vertical transmission of HIV infection. Int J Gynaecol Obstet 2001;73:279-281.
  6. WHO HIV and infant feeding technical consultation consensus statement. Geneva: WHO; 2006.
  7. Available at: http://www.unicef.org/India/children_2358.htm.
  8. Marcelo H Prevention of mother to child HIV transmission. Med 2006;66(1):24-30.
  9. Factor associated with readliness to VCT utilization among pregnant women attending antenatal clinics in northwestern Ethiopia: a health belief model approach. Thiop J Health Sci 2011 Aug;21(Suppl 1): 107-115.
  10. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006. AIDS 2008 May;22(8):973-981.
  11. Influence of highly active antiretroviral treatment (HAART) on risk factors for vertical HIV transmission. Acta Obstet Gynaecol Scand 2009;88(8):882-887.
  12. Correlates of anaemia in pregnant urban South Indian women: a possible role of dietary intake of nutrients that inhibit iron absorption. Public Health Nutr 2013 Feb;16(2):316-324.
  13. Combination antiretroviral strategies for the treatment of pregnant HIV 1 infected women and prevention of perinatal of perinatal HIV 1 transmission. J Acquire Immune Defic Syndr 2002 Apr;29(5):484-494.
  14. International recommendations on antiretroviral drugs for treatment of HIV infected women and prevention of mother-to-child HIV transmission in resource limited settings: 2006. Am J Obstet Gynecol 2007 Sep;197(Suppl 3):542-555.
  15. A trial of shortened zidovudine regimens to prevent mother to child transmission of human immunodeficiency virus type 1: Perinatal HIV Prevention Trial (Thailand) investigators. N Engl J Med 2000 Oct 5;343(14):982-991.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.